56 related articles for article (PubMed ID: 23463594)
1. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.
Tissot C; Toffart AC; Villar S; Souquet PJ; Merle P; Moro-Sibilot D; Pérol M; Zavadil J; Brambilla C; Olivier M; Couraud S
Eur Respir J; 2015 Dec; 46(6):1773-80. PubMed ID: 26493785
[TBL] [Abstract][Full Text] [Related]
2. Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival.
Orditura M; Romano C; De Vita F; Galizia G; Lieto E; Infusino S; De Cataldis G; Catalano G
Cancer Immunol Immunother; 2000 Dec; 49(10):530-6. PubMed ID: 11129323
[TBL] [Abstract][Full Text] [Related]
3. [Effect of peripheral blood inflammatory indicators on the efficacy of immunotherapy in patients with advanced non-small cell lung cancer and chronic obstructive pulmonary disease].
Bi ZK; Xu Y; Guo L; Zhang WJ; You YT; Li JW; Zhao CL; Shan YF; Xia TT; Li YF; Xu Z; Fan Y; Bai L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1601-1609. PubMed ID: 38742347
[No Abstract] [Full Text] [Related]
4. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Inoue Y; Inui N; Karayama M; Asada K; Fujii M; Matsuura S; Uto T; Hashimoto D; Matsui T; Ikeda M; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Suda T
Cancer Immunol Immunother; 2023 Aug; 72(8):2717-2728. PubMed ID: 37099186
[TBL] [Abstract][Full Text] [Related]
5. A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Ryan BM; Pine SR; Chaturvedi AK; Caporaso N; Harris CC
J Thorac Oncol; 2014 Oct; 9(10):1494-503. PubMed ID: 25170636
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer.
Ando K; Takahashi F; Kato M; Kaneko N; Doi T; Ohe Y; Koizumi F; Nishio K; Takahashi K
PLoS One; 2014; 9(7):e102436. PubMed ID: 25010770
[TBL] [Abstract][Full Text] [Related]
7. IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.
Rizzo M; Varnier L; Pezzicoli G; Pirovano M; Cosmai L; Porta C
Front Oncol; 2022; 12():990568. PubMed ID: 36059687
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Nutritional Status and Clinical Outcome in Patients Treated for Lung Cancer.
Polański J; Chabowski M; Świątoniowska-Lonc N; Dudek K; Jankowska-Polańska B; Zabierowski J; Mazur G
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684333
[TBL] [Abstract][Full Text] [Related]
9. Salidroside Suppresses the Proliferation and Migration of Human Lung Cancer Cells through AMPK-Dependent NLRP3 Inflammasome Regulation.
Ma W; Wang Z; Zhao Y; Wang Q; Zhang Y; Lei P; Lu W; Yan S; Zhou J; Li X; Yu W; Zhong Y; Chen L; Zheng T
Oxid Med Cell Longev; 2021; 2021():6614574. PubMed ID: 34457117
[TBL] [Abstract][Full Text] [Related]
10. LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis.
Wu LS; Liu Y; Wang XW; Xu B; Lin YL; Song Y; Dong Y; Liu JL; Wang XJ; Liu S; Kong P; Han M; Li BH
Cancer Manag Res; 2020; 12():10397-10409. PubMed ID: 33116894
[TBL] [Abstract][Full Text] [Related]
11. Nutritional status according to the mini nutritional assessment (MNA)® as potential prognostic factor for health and treatment outcomes in patients with cancer - a systematic review.
Torbahn G; Strauss T; Sieber CC; Kiesswetter E; Volkert D
BMC Cancer; 2020 Jun; 20(1):594. PubMed ID: 32586289
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group.
Tanriverdi O; Avci N; Oktay E; Kalemci S; Pilanci KN; Cokmert S; Menekse S; Kocar M; Sen CA; Akman T; Ordu C; Goksel G; Meydan N; Barutca S
Asian Pac J Cancer Prev; 2015; 16(14):5971-6. PubMed ID: 26320482
[TBL] [Abstract][Full Text] [Related]
14. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
[TBL] [Abstract][Full Text] [Related]
16. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
[TBL] [Abstract][Full Text] [Related]
17. Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.
Gioulbasanis I; Patrikidou A; Kitikidou K; Papadimitriou K; Vlachostergios PJ; Tsatsanis C; Margioris AN; Papandreou CN; Mavroudis D; Georgoulias V
Nutr Cancer; 2012; 64(1):41-7. PubMed ID: 22098075
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer.
Vlachostergios PJ; Gioulbasanis I; Ghosh S; Tsatsanis C; Papatsibas G; Xyrafas A; Hatzidaki E; Vasiliou C; Kamposioras K; Agelaki S; Margioris AN; Nasi D; Georgoulias V; Papandreou CN
Clin Transl Oncol; 2013 Nov; 15(11):903-9. PubMed ID: 23463594
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
